AstraZeneca

In News

AstraZeneca PLC (AZN) Investigation: Bronstein, Gewirtz & Grossma - The National Law Review

The National Law Review - Jul 17, 2026

Updated: Merck beats AstraZeneca to approval for first PCSK9 pill - Endpoints News

Endpoints News - Jul 16, 2026

Fierce Pharma Asia—GSK, Merck ADCs’ trial wins; AZ’s $1.5B EGFR buy; Biotechs’ new patent tricks - Fierce Pharma

Fierce Pharma - Jul 17, 2026

AstraZeneca (LSE:AZN) Stock Could Trade At A 46% Discount After Wainua Setback - Yahoo Finance

Yahoo Finance - Jul 15, 2026

Sidley steers Sino Biopharm, AstraZeneca licence agreement - Law.asia

Law.asia - Jul 16, 2026

AstraZeneca (AZN) Securities Investigation Notice - Levi & Korsinsky - Morningstar

Morningstar - Jul 16, 2026

AstraZeneca takes another China trip, picking Dizal’s lung cancer drug for up to $1.5B - BioSpace

BioSpace - Jul 14, 2026

AstraZeneca’s ALICIA Real‑World CLL Study Wraps Up, Setting Up Fresh Data for AZN Investors - TipRanks

TipRanks - Jul 17, 2026

AstraZeneca secures $1.5bn Chinese lung cancer drug deal - The Times

The Times - Jul 14, 2026

AstraZeneca to take rights to Dizal's lung cancer pill for $600M upfront - Endpoints News

Endpoints News - Jul 14, 2026

AstraZeneca enters exclusive global license agreement for novel oral EGFR inhibitor Zegfrovy for lung cancer with Dizal Pharmaceutical - AstraZeneca

AstraZeneca - Jul 14, 2026

AstraZeneca Enters Exclusive License Deal for Lung Cancer Drug Zegfrovy for Up to $1.5 Billion - WSJ

WSJ - Jul 14, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment